Search

Search Constraints

You searched for: Author/Creator Chan, Geoffrey

Search Results

1. Glasdegib in combination with cytarabine and daunorubicin in patients with AML or high‐risk MDS: Phase 2 study results. Issue 11 (9th September 2018)

2. An open-label, single-arm, phase 1 study to assess biomarker effects, efficacy and safety of ofatumumab in patients with refractory chronic lymphocytic leukemia. Issue 10 (3rd October 2015)

3. Anti-retinal IgG antibodies in patients with early and advanced type 2 macular telangiectasia. (May 2022)

5. Corrigendum to "Phase 1/2 trial of glasdegib in patients with primary or secondary myelofibrosis previously treated with ruxolitinib" [Leukemia Res. 79 (2019) 38–44]. (June 2019)